(Q34459067)

English

What is new in therapy?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

What is new in therapy? (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Ormerod AD

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

145

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

691-695

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

The treatment of psoriasis with IL-10: rationale and review of the first clinical trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Treatment of psoriasis with oral liarozole: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

First experience of topical SDZ ASM 981 in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Treatment of prurigo nodularis with topical capsaicin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Narrow-band ultraviolet B (ATL-01) phototherapy is an effective and safe treatment option for patients with severe seborrhoeic dermatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Pulsed-dye laser versus conventional therapy in the treatment of warts: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Imiquimod 5% cream in the treatment of Bowen's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

The state-of-the-art in chemoprevention of skin cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

The use of tetracyclines for the treatment of sarcoidosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Botulinum toxin type A therapy for palmar and digital hyperhidrosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2001.04503.X

21 January 2018

Identifiers

10.1046/J.1365-2133.2001.04503.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34459067&oldid=2037248068"